Visa's U.S. market share increased during the coronavirus pandemic, mostly as Americans used more debit cards. This is according to estimates based on the transaction volume of general purpose credit and debit cards issued in the United States. Visa's market share strengthened as time went by, moving from a roughly ** percent market share in 2007 to more than ** percent by 2022. This is likely because of the growing use of debit cards in the U.S. — causing the market share of American Express to decline. Debit cards grow faster than credit cards in the U.S. The number of cards issued by Visa reveals a growth disparity between their debit cards and their credit cards. The number of Visa issued debit cards in circulation in the U.S. in Q2 2023 had increased by *** percent when compared to the same period in the previous year. This growth figure was *** percent for U.S. Visa issued credit cards during the same period. By the second quarter, the United States had over *** million debit cards from Visa against roughly *** million Visa credit cards. Who uses debit cards in the United States? A three-year survey stated more than ***** out of 10 respondents from the United States owned a debit card in 2021, with only ** percent actually having used one. Women were much more likely than men to own such a payment card. Gen Z — or the age group 15 to 24 years in this survey — was less likely to own a debit card than their older counterparts, although their ownership of debit cards was much higher when compared to Gen Z credit card ownership.

In 2024, Visa still had the majority of all general purpose card payments within the Latin America region - although its market share remained relatively unchanged. Mastercard followed, accounting for about ** percent of the purchase volume in the region that year. This is somewhat of a decline of its position as between 2018 and 2019 MasterCard's market share increased in favor of that of American Express. In 2024, Brazil was the Latin American country with the highest number of credit cards.

UnionPay's global market share grew faster than that of MasterCard, whilst Visa's worldwide market position declined. This does not imply that Visa's transaction volume worldwide declined: It increased by roughly ** billion purchases between 2021 and 2022. Compared to the number of transactions from UnionPay and MasterCard, however, Visa's transactions did not increase as much - leading to a declining market share.

Mastercard's purchase volume in the United States increased by roughly *** billion dollars in 2024, which was less than Visa's increase. Visa's market share in the U.S. especially increased during the coronavirus pandemic, mostly as Americans used more debit cards. The growing use of debit cards in the U.S. may explain why the market share of American Express declined compared to the other schemes.

Discover Market Research Intellect's Apps Discovery Platform Market Report, worth USD 2.5 billion in 2024 and projected to hit USD 6.8 billion by 2033, registering a CAGR of 12.3% between 2026 and 2033.Gain in-depth knowledge of emerging trends, growth drivers, and leading companies.

Explore Market Research Intellect's Payment Card Market Report, valued at USD 2.5 trillion in 2024, with a projected market growth to USD 4.5 trillion by 2033, and a CAGR of 7.5% from 2026 to 2033.

The Small Molecule Drug Discovery Market is Segmented by Therapeutic Area (Oncology, Cardiovascular, and More), Process/Phase (Target Identification & Validation and More), Drug Type (Synthetic Small Molecules and More), Technology (High-Throughput Screening (HTS) and More), End User (Pharmaceutical Companies, and More) and Geography (North America and More). The Market and Forecasts are Provided in Terms of Value (USD).

• The global industry was valued at US$ 1.6 Bn in 2023
• It is expected to grow at a CAGR of 10.1% from 2024 to 2034 and reach US$ 4.8 Bn by the end of 2034

Antibody Discovery Market Overview

Regional Analysis of Antibody Discovery Adoption and Usage Patterns

Global Antibody Discovery Market Snapshot

Future Market Insights’ updated report estimates the global antibody discovery market size to grow by 2.6X over the next ten years- from US$ 8.5 billion in 2024 to US$ 21.8 billion by 2034.

A Brief Glimpse of Historical Growth Vs. Future Projections Comparison

Country-wise Insights

Category-wise Insights

Sensitive Data Discovery Market size was valued at USD 7.50 Billion in 2023 and is projected to reach USD 20.03 Billion by 2030, growing at a CAGR of 15.5% during the forecast period 2024-2030.

Global Sensitive Data Discovery Market Drivers

The market drivers for the Sensitive Data Discovery Market can be influenced by various factors. These may include:

Growing Concerns about Cybersecurity and Data Breaches: Organisations now realise how critical it is to secure sensitive data due to the increasing frequency and severity of data breaches. Solutions for sensitive data discovery become essential for locating and safeguarding sensitive data, which helps to solve cybersecurity issues.

Regulatory Compliance Requirements: Strict privacy and data protection laws are being enforced by governments and regulatory organisations across the globe. Organisations must put in place methods for locating and handling sensitive data in order to comply with regulations like the General Data Protection Regulation, the Health Insurance Portability and Accountability Act, and others.

Proliferation of Data Across Organisations: It is becoming more difficult to manually track and secure sensitive information due to the ever-growing volume of data collected and processed by organisations. Organisations can manage the massive volumes of data they handle with the aid of automated sensitive data discovery solutions.

Adoption of Cloud Services: Switching to cloud services creates new difficulties for data security maintenance. Ensuring that data stored in the cloud is appropriately recognised, classified, and safeguarded becomes dependent on sensitive data discovery.

Growing Awareness and Education: Organisations are placing a greater emphasis on training and education as they become more conscious of the possible risks connected to the exposure of sensitive data. Sensitive data discovery is growing because businesses are investing in technology that make it easier to find and safeguard sensitive data.

Integration with Security Ecosystem: Data Loss Prevention (DLP), Endpoint Protection, and Security Information and Event Management (SIEM) systems are just a few examples of the larger cybersecurity ecosystems into which sensitive data discovery solutions are frequently integrated. The adoption of these integrated solutions is motivated by the requirement for a thorough security approach.

Growing Insider Threats: Sensitive data is at serious danger from insider threats, whether deliberate or inadvertent. Organisations can identify and reduce the risks related to insider threats with the use of sensitive data discovery technologies.

Globalisation and Cross-Border Data Flow: Companies that conduct business internationally must abide by various data protection regulations in various countries. Sensitive data discovery ensures the safe transfer of data across borders by helping to manage compliance with various regulations.

Global Artificial Intelligence in Drug Discovery Market was valued at USD 1.2 Billion in 2023 and expected to reach USD 13.6 Billion by 2033

The Drug Discovery Informatics Market Report is Segmented by Function (Sequencing & Target Data Analysis, and More), End User (Pharmaceutical Companies, and More), Solution (Software and Services), Workflow (Discovery Informatics and Development Informatics), Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Sensitive Data Discovery Market is poised to witness substantial growth, reaching a value of USD 41.46 Billion by the year 2033, up from USD 10.47 Billion attained in 2024. The market is anticipated to display a Compound Annual Growth Rate (CAGR) of 16.52% between 2025 and 2033.

The Global Sensitive Data Discovery market size to cross USD 41.46 Billion by 2033. [https://edison.valuemarketr

The report offers Biologics Drug Discovery Market Dynamics, Comprises Industry development drivers, challenges, opportunities, threats and limitations. A report also incorporates Cost Trend of products, Mergers & Acquisitions, Expansion, Crucial Suppliers of products, Concentration Rate of Steel Coupling Economy. Global Biologics Drug Discovery Market Research Report covers Market Effect Factors investigation chiefly included Technology Progress, Consumer Requires Trend, External Environmental Change.

Drug Discovery Outsourcing Market size with a CAGR of 6.4% in the prediction period and it crosses USD 6,685.1 Mn in 2032 from USD 4,330.3 Mn in 2025.

The Meso Scale Discovery (MSD) assay services market is experiencing robust growth, driven by the increasing demand for high-throughput, sensitive, and multiplexed assays in pharmaceutical research, clinical diagnostics, and biomarker discovery. The market's expansion is fueled by the rising prevalence of chronic diseases necessitating advanced diagnostic tools and the burgeoning biopharmaceutical industry's need for efficient drug development processes. Technological advancements in MSD platforms, offering enhanced sensitivity and multiplexing capabilities, further contribute to market growth. Specifically, the S-Plex and V-Plex technologies are key drivers, offering advantages in terms of assay speed and data quality. While the market faces some restraints, such as the high cost of instrumentation and specialized expertise required, the overall market outlook remains positive due to continuous innovation and increasing adoption across various research and diagnostic settings. Considering a conservative CAGR of 10% (based on typical growth in related advanced diagnostic sectors), and a 2025 market size of $500 million (a reasonable estimate based on market analysis of comparable technologies), the market is projected to reach approximately $1.2 billion by 2033. Regional market penetration varies, with North America currently dominating due to the high concentration of research institutions and pharmaceutical companies, followed by Europe and Asia Pacific. The competitive landscape is fragmented, with several key players offering a range of MSD assay services. These companies are constantly innovating to enhance their offerings and expand their market share. Strategic collaborations and partnerships are also becoming increasingly important in this space, allowing companies to access new technologies and expand their reach. Future growth will be influenced by factors such as the development of novel biomarkers, advancements in automation and data analysis, and regulatory approvals for new diagnostic applications. The increasing adoption of personalized medicine is also expected to drive demand for high-throughput MSD assays, supporting the continued growth of this specialized market segment.

Drug Discovery Market size was valued at USD 53.1 Billion in 2024 and is projected to reach USD 94.23 Billion by 2032, growing at a CAGR of 8.20% from 2026 to 2032.

Drug Discovery Market: Definition/ Overview

Drug discovery is a multidisciplinary process involving biology, chemistry, pharmacology, and computational science to identify and develop new medications. It starts with target identification, followed by target validation and high-throughput screening techniques. Compounds are optimized for efficacy, side effects, and pharmacokinetic properties. These compounds undergo preclinical studies, including in vitro and in vivo experiments, before advancing to clinical trials.

The drug discovery outsourcing market will grow from USD 4.9 Billion in 2025 to USD 11.7 Billion by 2035, driven by clinical trials, with a CAGR of 8.4%.

Explore insights from Market Research Intellect's Drug Discovery Services Market Report, valued at USD 62. 4 billion in 2024, expected to reach USD 113. 6 billion by 2033 with a CAGR of 7. 8% during 2026–2033. Uncover opportunities across demand patterns, technological innovations, and market leaders.

The global G-protein coupled receptors market size is estimated to reach over USD 6,053.55 Mn by 2032, advancing from USD 3,630.53 Mn in 2024, with an increase of USD 3,805.45 Mn in 2025, growing at a CAGR of 6.6% from 2025 to 2032.